FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,619,877 | -14.9% | 4,077,214 | 0.0% | 0.68% | -12.4% |
| Q2 2023 | $36,001,800 | +6.1% | 4,077,214 | 0.0% | 0.78% | +1.6% |
| Q1 2023 | $33,922,420 | -13.3% | 4,077,214 | 0.0% | 0.77% | -23.9% |
| Q4 2022 | $39,141,254 | +18.5% | 4,077,214 | 0.0% | 1.01% | +13.6% |
| Q3 2022 | $33,025,000 | +45.2% | 4,077,214 | 0.0% | 0.89% | +38.0% |
| Q2 2022 | $22,751,000 | -0.4% | 4,077,214 | 0.0% | 0.64% | +45.6% |
| Q1 2022 | $22,832,000 | +27.3% | 4,077,214 | 0.0% | 0.44% | +28.8% |
| Q4 2021 | $17,940,000 | -53.3% | 4,077,214 | 0.0% | 0.34% | -58.0% |
| Q3 2021 | $38,407,000 | +29.2% | 4,077,214 | 0.0% | 0.82% | +59.2% |
| Q2 2021 | $29,723,000 | -41.3% | 4,077,214 | -50.0% | 0.52% | +24.7% |
| Q1 2021 | $50,638,000 | +66.7% | 8,154,428 | +100.0% | 0.41% | -22.1% |
| Q4 2020 | $30,375,000 | +22.9% | 4,077,214 | 0.0% | 0.53% | -5.7% |
| Q3 2020 | $24,708,000 | -27.4% | 4,077,214 | 0.0% | 0.56% | -32.3% |
| Q2 2020 | $34,045,000 | +43.4% | 4,077,214 | +2.0% | 0.83% | +19.6% |
| Q1 2020 | $23,743,000 | -8.5% | 3,997,214 | 0.0% | 0.69% | -25.7% |
| Q4 2019 | $25,942,000 | +34.9% | 3,997,214 | 0.0% | 0.93% | +28.7% |
| Q3 2019 | $19,227,000 | +20.3% | 3,997,214 | 0.0% | 0.73% | +20.2% |
| Q2 2019 | $15,989,000 | -17.5% | 3,997,214 | 0.0% | 0.60% | -26.6% |
| Q1 2019 | $19,386,000 | -24.0% | 3,997,214 | 0.0% | 0.82% | -33.3% |
| Q4 2018 | $25,502,000 | -22.2% | 3,997,214 | 0.0% | 1.23% | -2.6% |
| Q3 2018 | $32,777,000 | -21.5% | 3,997,214 | 0.0% | 1.27% | -28.6% |
| Q2 2018 | $41,731,000 | -13.7% | 3,997,214 | 0.0% | 1.77% | -17.2% |
| Q1 2018 | $48,346,000 | +20.7% | 3,997,214 | 0.0% | 2.14% | +12.4% |
| Q4 2017 | $40,052,000 | -9.6% | 3,997,214 | 0.0% | 1.91% | +4.8% |
| Q3 2017 | $44,329,000 | – | 3,997,214 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |